市場調査レポート
商品コード
1370513
褥瘡治療市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測Pressure Ulcers Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
褥瘡治療市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測 |
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の褥瘡治療市場規模は2022年に50億米ドルに達しました。今後、IMARC Groupは、同市場が2023年から2028年の間に5.18%の成長率(CAGR)を示し、2028年までに69億米ドルに達すると予測しています。
褥瘡(床ずれ)とも呼ばれる褥瘡は、皮膚への長時間の圧迫や剪断力によって引き起こされる皮膚や下層組織の変性損傷です。褥瘡は通常、背中、臀部、尾骨、かかと、肘、肩、足首など、身体の骨や筋肉の部分に生じる。特に、感覚障害、栄養不良、併存疾患、長時間の不動などを有する集団では、罹患率および死亡率が高くなります。褥瘡は、筋肉や骨が露出した深いクレーターを予防するための適切な予防策と薬物療法によって治癒します。褥瘡の治療には、壊死組織の除去、患部皮膚への圧力の軽減、創傷のケア、疼痛のコントロール、創傷治癒のための良好な栄養状態と湿潤環境の維持が含まれます。また、通常の生理食塩水による創傷の洗浄や、感染部位に適切なドレッシング材を使用することも必要です。このほか、潰瘍を早期に発見し治療することで、骨や関節の感染、蜂窩織炎、敗血症、がんなどの合併症のリスクを最小限に抑えることができます。
皮膚の脆弱性や細胞層の薄化、毛細血管密度や細胞増殖の低下により褥瘡を発症しやすくなる世界の老年人口の増加は、市場にプラスの影響を与える主な要因の1つです。加えて、肥満や慢性疾患の増加が褥瘡の急増を招いています。これとは別に、褥瘡の早期診断に関する個人の意識の高まりや、治療が容易に受けられることも市場の成長に寄与しています。さらに、病院、診療所、薬局、ドラッグストアの拡大とヘルスケア産業における技術進歩のイントロダクションが、市場の見通しを明るいものにしています。さらに、市場大手各社が新規創傷ケア製品の処方に注力し始めていることも、市場を牽引すると予想されます。
The global pressure ulcers treatment market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.18% during 2023-2028.
Pressure ulcers, also known as bedsores, are degenerative skin and underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They usually affect the bony and muscle areas of the body, such as back, buttocks, tailbone, heels, elbow, shoulder, and ankles. They lead to morbidity and mortality, especially among the masses with impaired sensation, poor nutrition, comorbidities, and prolonged immobility. They are cured by appropriate preventive measures and medications that help prevent deep craters with exposed muscle and bone. Pressure ulcers treatment involves removing necrotic tissue, reducing pressure on the affected skin, caring for wounds, controlling pain, and maintaining good nutrition and a moist environment for wound healing. It also involves wound cleansing with normal saline and appropriate dressings for the infected area. Besides this, early identification and treatment of these ulcers minimize the risk of complications, including bone and joint infections, cellulitis, sepsis, and cancer.
The increasing global geriatric population, which is more susceptible to developing pressure ulcers due to skin fragility and thinning of the cell layers and decreased capillary density and cell growth represents one of the key factors positively influencing the market. In addition, the increasing prevalence of obesity and chronic medical diseases is resulting in the surging occurrence of pressure ulcers. Apart from this, the rising awareness among individuals about the early diagnosis of bedsores, along with the easy availability of treatment, is also contributing to the market growth. Furthermore, the expansion of hospitals, clinics, pharmacies, and drug stores, coupled with the introduction of technological advancements in the healthcare industry, is creating a positive market outlook. Additionally, the rising focus of leading market players on the formulation of novel wound care products is anticipated to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pressure ulcers treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on ulcer type, product type and end user.
Stage 1
Stage 2
Stage 3
Stage 4
Wound-Care Dressings
Wound-Care Devices
Others
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Molnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.